• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

ViCentra now offers Kaleido insulin pump in the Netherlands

March 24, 2023 By Sean Whooley

ViCentra Kaleido Insulin Pump
The Kaleido insulin pump. [Image from ViCentra]
ViCentra recently announced that it made its Kaleido insulin pump system available for users in the Netherlands.

Utrecht, the Netherlands-based ViCentra designed its insulin pump system as a small, light and accurate platform. The company says the system “lets people with diabetes live life on their own terms.”

Kaleido features pulse technology that provides continuous micro-dosing of insulin. With a simple appearance — and 10 color combination options — the user can personalize their treatment in many ways.

Each user can choose to wear the discreet pump directly on the body or in its pocket when using its longer tubing option.

As of March 14, healthcare providers in the Netherlands can prescribe Kaleido.

“I am very happy we can announce that Kaleido is now available to more users in the Netherlands,” said ViCentra CEO Frans Cromme. “A highly engaged group of 70 users have been using Kaleido intensively in the last 12 months, providing feedback on both the product and our services, such as our training and our customer care team. We are very satisfied with the results, and are now ready to make Kaleido available to more people with diabetes.”

More about the ViCentra Kaleido insulin pump

ViCentra said it invested heavily in recent months to increase production capacity. It moved to a new location in Utrecht with “certified modern production.”

Cromme said this move allows the company to supply Kaleido to “a large group of users in other European markets this year.” The company also plans to continue its growth to more than 150 employees in the Netherlands and abroad.

Later this year, ViCentra plans to make Kaleido available in combination with the DBLG1 system from Diabeloop. This advanced hybrid closed-loop system uses the Dexcom 6 CGM, too.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: kaleido, ViCentra

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS